CATHERINE CARTER: Open Payments
NPI 1245510627 · TOOELE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 22 payments from 13 companies in 2025. Trend: 2023 $653 · 2024 $438 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $88 |
| Viatris Specialty LLC | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| ABBVIE INC. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Astellas Pharma US Inc | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $18 |
| Medtronic, Inc. | 1 | $18 |
Products named: Sunosi, YUPELRI, BREZTRI, REXULTI, VRAYLAR, CAPLYTA, Veozah, JARDIANCE.
Industry payments across UT — which companies pay providers there.
